(Panel Discussion) Celebrity recreational use has already helped destigmatize marijuana. And in future, all kinds of spokespeople could play a part in the normalizing and marketing of it. Celebs as diverse as Jennifer Aniston, Miley Cyrus, Brad Pitt, Bill Maher, Kirsten Dunst and Woody Harrelson have indicated they are pro-pot. Will endorsing it be considered a good career move? And how influential will they be when it comes to carving market share? Moderator: Leonard Glickman, Partner, Cassels Brock & Blackwell, LLP
(Presentation) Your cannabis business is very appealing to cyber criminals: trade secrets, financial information, confidential data of customers and vendors, email accounts, ransom money and more. Without proper protection, cyber threats can put your organization’s operations, reputation – even its existence – at risk. Cyber security is now an urgent business imperative for every cannabis company of every size and at every stage, from startup to exit. In this session you'll learn how cyber attacks are evolving and the steps you should take immediately to protect your business from cyber attackers. Presented by: MNP LLP
The Canadian Consumer Market: Understanding Market Size, Usage Behavior and Relevant Attitudes Among Cannabis Users
(Panel Discussion) This session will provide Canadian insights from the Cannabis Consumer Update. They include: who is using, how much cannabis, in what form. We will also cover findings regarding strain awareness and trial as well as important consumer attitudes such as: price/quality, impression of Producers, usage occasions and more. Moderator: Sunny Freeman, Resources Report, Financial Post
(Panel Discussion) The black market has been the only game we’ve known since the Jazz Age. But now that legalization looms, the players in a legitimized cannabis industry are searching for best-case distribution scenarios. Liquor stores have experience in serving responsible adults while keeping product out of the hands of minors. Dispensaries have specialized expertise. Pharmacies do too with medical expertise to boot. And major chains like Shoppers Drug Mart already want in. This panel will look at the best cases for each market scenario. Moderator: Dr.Paul Roumeliotis, Medical Health Officer, Child Health & Wellness for Parents Worldwide, Eastern Ontario Health Unit
(Panel Discussion) To those who say there hasn’t been enough testing of marijuana, Tommy Chong once said, “I’ve been testing it for 50 years.” Ironically, he has a point. From sheer mass use, there is plenty we do know about the efficacy of cannabis as a medicine, as well as cautionary notes. Physicians who prescribe it have a pretty good idea what it can do, what it can’t, and how it should be applied. In this session we separate facts from fiction. Moderator: Dr. Danial Schecter, Executive Director, Cannabinoid Medical Clinic
(Presentation) Using Medical Cannabis for Opioids Sparing and Tapering in Chronic Pain". The presentation provides literature on the topic, and he will discuss how medical cannabis can be used as an adjunct medication for opioid sparing or withdrawal. He will focus on how cannabis has effects on opioid and cannabinoid receptors and is much safer than opioids. Dr. Smith will provide education on how to use medical cannabis for opioid sparing and withdrawal.
(Closing Keynote) Tracy Ryan’s daughter Sophie was diagnosed with a rare brain tumor at 8 1/2 months old. After watching her own daughter defy every odd medical doctors placed against her that was a result of her cannabis oil use, Tracy launched CannaKids and SavingSophie.org. Tracy has consulted with thousands of patients around the globe on cannabis use and education, and has treated over 500 patients in the last year and a half in California with her own line of CannaKids’ Honey Gold cannabis oils. With a true passion for clinical research, Tracy has successfully secured a relationship with the Technion Institute in Israel who are leading the way in cannabis research for cancer. Her [...]
(Presentation) Cannabis has been used as a medicine for thousands of years. We have only started to stigmatize this plant over the last century. It is known to help with inflammation, seizures and pain as well as many other ailments. Recent developments have shown that cannabis treatments can be extremely beneficial in treating cancer, epilepsy, autism, chronic diseases, and many other conditions. We all have an Endocannabinoid System in our bodies, but sadly most of us do not understand what is does for us. The Endocannabinoid System as a mechanism for drug interaction is widely unexplored and the true potential for positive impact on human health is unknown. This presentation will provide a physician’s [...]
(Featured Keynote) Maya will be speaking about how to keep cannabis compassionate, treating cannabis as a superfood and healing herb with a focus on respecting the farmer and keep our industry full of integrity.
(Panel Discussion) If a product is legal for sale, it follows that sellers will want to spread the word. And a marketplace of sellers will be jockeying to create preferential brand awareness. Yes, that means some form of advertising and marketing. But what pot ads will look like in a regulated environment is still unclear. Will there be restrictions on “lifestyle” ads? On mascots because of the appeal to youth? Will some media, like TV, be off-limits? This is one commercial break that’s definitely worth your time. Morderator: Dooma Wendschuh, Co-Founder & CEO, Province Presented by: Rouge Media Group